Karel Sonka Selected Research

Therapeutics

11/2021	Defining Speech Subtypes in De Novo Parkinson Disease: Response to Long-term Levodopa Therapy.
1/2018	Smartphone Allows Capture of Speech Abnormalities Associated With High Risk of Developing Parkinson's Disease.
1/2017	Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial.
9/2012	Diagnosis and management of central hypersomnias.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karel Sonka Research Topics

Disease

16	Narcolepsy 01/2022 - 02/2006
11	Cataplexy 01/2022 - 02/2006
6	Disorders of Excessive Somnolence (Hypersomnia) 01/2022 - 09/2003
4	REM Sleep Behavior Disorder 01/2022 - 01/2015
4	Parkinson Disease (Parkinson's Disease) 11/2021 - 07/2010
3	Idiopathic Hypersomnia 01/2022 - 10/2016
3	Synucleinopathies 01/2022 - 01/2018
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2018
3	Dementia (Dementias) 01/2022 - 05/2015
3	Restless Legs Syndrome (Restless Legs) 08/2008 - 09/2003
2	Parkinsonian Disorders (Parkinsonism) 01/2022 - 05/2015
1	Parasomnias (Parasomnia) 01/2022
1	Cognitive Dysfunction 01/2022
1	Depressive Disorder (Melancholia) 12/2021
1	Nausea 01/2017
1	Headache (Headaches) 01/2017
1	Sleepiness 10/2016
1	Necrosis 08/2014
1	Lung Diseases (Lung Disease) 03/2014
1	Sleep Wake Disorders 01/2014
1	Movement Disorders (Movement Disorder) 06/2012
1	Apnea 09/2011
1	Weight Gain 12/2010
1	Spontaneous Abortion (Miscarriage) 12/2010
1	Obesity 01/2010
1	Carotid Stenosis (Carotid Artery Stenosis) 03/2009
1	Stroke (Strokes) 10/2007
1	Craniocerebral Trauma (Head Injury) 10/2007
1	Obstructive Sleep Apnea 10/2007

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
5	Antidepressive Agents (Antidepressants)IBA 12/2021 - 02/2006
4	Modafinil (Provigil)FDA Link 12/2021 - 09/2012
4	Sodium Oxybate (gamma Hydroxybutyrate)FDA Link 12/2021 - 01/2010
4	OrexinsIBA 08/2014 - 01/2010
3	N-(4-aminophenethyl)spiroperidol (NAPS)IBA 01/2022 - 01/2021
3	pitolisantIBA 12/2021 - 01/2017
3	Methylphenidate (Ritalin)FDA LinkGeneric 12/2021 - 09/2012
2	Amphetamine (Amfetamine)FDA LinkGeneric 12/2021 - 01/2021
2	Clomipramine (Anafranil)FDA LinkGeneric 12/2021 - 01/2021
2	solriamfetolIBA 12/2021 - 01/2021
2	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 12/2021 - 01/2021
2	HLA-DQB1 antigen (HLA DQB1)IBA 12/2021 - 12/2016
2	Glucose (Dextrose)FDA LinkGeneric 08/2014 - 10/2013
1	Coffee FDA Link 01/2022
1	SynucleinsIBA 01/2022
1	VortioxetineIBA 12/2021
1	Levodopa (L Dopa)FDA LinkGeneric 11/2021
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2020
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 01/2017
1	Aminobutyrates (Aminobutyric Acid)IBA 10/2016
1	Clonazepam (Rivotril)FDA LinkGeneric 05/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 08/2014
1	CytokinesIBA 08/2014
1	Corticotropin-Releasing HormoneIBA 08/2014
1	Hydrocortisone (Cortisol)FDA LinkGeneric 08/2014
1	Interleukin-6 (Interleukin 6)IBA 08/2014
1	GlucocorticoidsIBA 03/2014
1	Pharmaceutical PreparationsIBA 01/2014
1	Cathepsin HIBA 01/2013
1	OX40 LigandIBA 01/2013
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2013
1	Central Nervous System StimulantsIBA 09/2012
1	Sertraline (Zoloft)FDA LinkGeneric 06/2012
1	Oxygen (Dioxygen)IBA 09/2011
1	Hemoglobins (Hemoglobin)IBA 09/2011
1	Nicotine FDA Link 12/2010
1	ropinirole (Requip)FDA LinkGeneric 07/2010
1	Protein Tyrosine PhosphatasesIBA 08/2008
1	Proteins (Proteins, Gene)FDA Link 10/2007
1	Erythropoietin FDA Link 10/2007
1	Escitalopram FDA Link 02/2006
1	dironyl (terguride)IBA 09/2003

Therapy/Procedure

4	Therapeutics 11/2021 - 09/2012
1	Cesarean Section (Caesarean Section) 10/2013
1	Endarterectomy (Thromboendarterectomy) 03/2009